Amarin Corp Plcuk (AMRN) Gross Margin Growth (3y) (2016 - 2026)
Amarin Corp Plcuk (AMRN) Gross Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -178.00 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 532.00 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 30.00 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 455.00 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 77.00 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -201.00 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 162.00 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 6,553.00 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -3.00 |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | -1,771.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,771.00 |
| Mar 31, 2026 | -1,637.00 |
| Dec 31, 2025 | -2,341.00 |
| Sep 30, 2025 | -2,523.00 |
| Jun 30, 2025 | 2,304.00 |
| Mar 31, 2025 | -1,669.00 |
| Dec 31, 2024 | -9,415.00 |
| Sep 30, 2024 | -4,025.00 |
| Jun 30, 2024 | -1,582.00 |
| Mar 31, 2024 | -2,363.00 |
| Dec 31, 2023 | -1,882.00 |
| Sep 30, 2023 | -3,372.00 |
| Jun 30, 2023 | -2,549.00 |
| Mar 31, 2023 | -2,180.00 |
| Dec 31, 2022 | -812.00 |
| Sep 30, 2022 | -743.00 |
| Jun 30, 2022 | -3,121.00 |
| Mar 31, 2022 | -11.00 |
| Dec 31, 2021 | 144.00 |
| Sep 30, 2021 | 321.00 |